Index S&P 500
P/E 33.67
EPS (ttm) 6.50
Insider Own 0.80%
Shs Outstand 147.06M
Perf Week 0.39%
Market Cap 32.14B
Forward P/E 24.97
EPS next Y 8.76
Insider Trans -4.49%
Shs Float 145.80M
Perf Month 22.30%
Income 958.38M
PEG 2.59
EPS next Q 2.08
Inst Own 58.27%
Short Float 6.76%
Perf Quarter 21.08%
Sales 4.58B
P/S 7.01
EPS this Y 19.97%
Inst Trans -0.38%
Short Ratio 9.00
Perf Half Y 46.90%
Book/sh 31.52
P/B 6.94
EPS next Y 13.37%
ROA 14.17%
Short Interest 9.85M
Perf Year -2.44%
Cash/sh 1.62
P/C 135.07
EPS next 5Y 13.00%
ROE 22.39%
52W Range 132.24 - 229.97
Perf YTD 27.16%
Dividend Est. 1.95 (0.89%)
P/FCF 29.49
EPS past 5Y 22.66%
ROI 16.63%
52W High -4.88%
Beta 0.70
Dividend TTM 1.92 (0.88%)
Quick Ratio 1.97
Sales past 5Y 12.58%
Gross Margin 54.74%
52W Low 65.41%
ATR (14) 5.29
Dividend Ex-Date May 08, 2024
Current Ratio 3.04
EPS Y/Y TTM 10.74%
Oper. Margin 28.12%
RSI (14) 63.72
Volatility 1.84% 2.32%
Employees 10140
Debt/Eq 0.25
Sales Y/Y TTM 14.16%
Profit Margin 20.91%
Recom 1.73
Target Price 219.88
Option/Short Yes / Yes
LT Debt/Eq 0.24
EPS Q/Q 29.19%
Payout 28.91%
Rel Volume 0.46
Prev Close 218.57
Sales Surprise 1.94%
EPS Surprise 10.51%
Sales Q/Q 7.17%
Earnings Apr 25 AMC
Avg Volume 1.09M
Price 218.74
SMA20 4.14%
SMA50 10.75%
SMA200 27.15%
Trades
Volume 500,230
Change 0.08%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$227
Oct-27-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$180 → $169
Oct-12-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$273 → $202
Oct-09-23 Upgrade
JP Morgan
Neutral → Overweight
$210 → $170
Sep-29-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-06-23 Upgrade
Needham
Hold → Buy
$180
Sep-05-23 Downgrade
UBS
Buy → Neutral
$265 → $170
Aug-01-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$262 → $284
May-23-23 Initiated
UBS
Buy
$290
Apr-14-23 Initiated
Mizuho
Buy
$255
Jan-17-23 Upgrade
JP Morgan
Neutral → Overweight
$245
Oct-28-22 Downgrade
Citigroup
Buy → Neutral
Oct-20-22 Upgrade
BofA Securities
Neutral → Buy
$245 → $260
Oct-12-22 Initiated
Jefferies
Hold
Sep-08-22 Upgrade
Citigroup
Neutral → Buy
Aug-15-22 Downgrade
CLSA
Buy → Outperform
Aug-12-22 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$246 → $252
Aug-12-22 Downgrade
JP Morgan
Overweight → Neutral
Aug-12-22 Downgrade
Citigroup
Buy → Neutral
Jun-06-22 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$233 → $244
Show Previous Ratings
May-20-24 10:47AM
May-16-24 04:35PM
12:00PM
08:05AM
May-15-24 12:45PM
09:45AM
Loading…
09:45AM
May-08-24 10:31AM
May-07-24 04:05PM
May-03-24 09:43AM
Apr-30-24 01:31PM
09:50AM
Apr-29-24 12:45PM
09:45AM
Apr-27-24 01:06AM
Apr-26-24 04:08PM
(Investor's Business Daily) +18.89%
03:57PM
Loading…
03:57PM
02:12PM
01:48PM
12:17PM
12:08PM
11:45AM
(The Wall Street Journal)
11:35AM
11:26AM
11:01AM
10:33AM
10:12AM
10:00AM
(Investor's Business Daily)
08:58AM
08:47AM
08:37AM
08:07AM
Loading…
08:07AM
07:53AM
06:39AM
06:33AM
(Thomson Reuters StreetEvents)
06:16AM
03:36AM
Apr-25-24 06:30PM
05:43PM
05:25PM
04:49PM
04:22PM
(Associated Press Finance)
04:05PM
11:34AM
Apr-22-24 09:16AM
Apr-18-24 04:02PM
(Investor's Business Daily)
10:01AM
Apr-17-24 06:51PM
04:09PM
(Investor's Business Daily)
12:08PM
09:43AM
(The Wall Street Journal)
Apr-04-24 04:05PM
Apr-01-24 12:44PM
Mar-30-24 11:49AM
Mar-15-24 03:05AM
Mar-07-24 09:45AM
07:33AM
Mar-06-24 09:05AM
Feb-24-24 03:10AM
Feb-23-24 11:30AM
Feb-22-24 09:53AM
Feb-20-24 01:35PM
Feb-18-24 01:26PM
Feb-16-24 10:26AM
10:00AM
(The Wall Street Journal)
Feb-13-24 10:23AM
Feb-12-24 04:16PM
Feb-07-24 08:05AM
Feb-05-24 09:45AM
Jan-29-24 04:09PM
10:56AM
12:30AM
Jan-26-24 09:15PM
09:50AM
12:12AM
Jan-25-24 04:05PM
(Investor's Business Daily) +8.48%
12:38PM
(Thomson Reuters StreetEvents)
12:07PM
12:04PM
11:03AM
10:33AM
(Investor's Business Daily)
09:03AM
(Investor's Business Daily)
06:12AM
Jan-24-24 07:00PM
06:07PM
05:25PM
05:22PM
04:43PM
04:27PM
(Associated Press Finance)
04:05PM
Jan-23-24 10:29AM
Jan-19-24 01:05PM
Jan-17-24 12:05PM
09:45AM
Jan-16-24 07:56AM
Jan-12-24 12:58AM
Jan-11-24 05:50PM
Jan-03-24 04:05PM
Dec-27-23 04:05PM
Dec-21-23 11:50PM
Dec-20-23 04:05PM
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
De Witte Jan Director May 15 '24 Sale 218.29 360 78,584 7,519 May 17 11:27 AM Sandercock Brett Chief Financial Officer May 08 '24 Option Exercise 101.64 12,000 1,219,680 105,056 May 10 03:21 PM Sandercock Brett Chief Financial Officer May 08 '24 Sale 211.37 13,000 2,747,810 92,056 May 10 03:21 PM Farrell Michael J. Chief Executive Officer May 07 '24 Option Exercise 84.98 14,683 1,247,761 455,435 May 09 11:58 AM Farrell Michael J. Chief Executive Officer May 07 '24 Sale 216.50 14,683 3,178,815 440,752 May 09 11:58 AM Drexler Karen Director Apr 29 '24 Sale 214.92 425 91,341 8,446 Apr 30 02:17 PM Rider Michael J Global General Counsel Mar 04 '24 Sale 180.00 81 14,580 6,607 Mar 06 08:46 PM Rider Michael J Global General Counsel Mar 01 '24 Sale 173.25 200 34,650 6,688 Mar 04 07:11 PM FARRELL PETER C Director Feb 22 '24 Sale 182.66 10,935 1,997,434 157,404 Feb 23 06:40 PM Sandercock Brett Chief Financial Officer Nov 27 '23 Sale 152.62 3,000 457,860 92,962 Nov 29 07:45 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Option Exercise 57.76 5,678 327,961 446,664 Nov 16 09:20 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Sale 152.04 5,678 863,281 440,986 Nov 16 09:20 PM Rider Michael J Global General Counsel Nov 01 '23 Sale 143.42 25 3,585 7,358 Nov 02 09:29 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Option Exercise 57.76 5,675 327,788 455,035 Oct 17 06:50 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Sale 140.70 5,675 798,464 449,360 Oct 17 06:50 PM Rider Michael J Global General Counsel Oct 02 '23 Sale 145.92 25 3,648 7,383 Oct 04 10:57 AM Farrell Michael J. Chief Executive Officer Sep 15 '23 Option Exercise 57.76 5,675 327,788 455,035 Sep 19 02:54 PM Farrell Michael J. Chief Executive Officer Sep 15 '23 Sale 146.35 5,675 830,514 449,360 Sep 19 02:54 PM Rider Michael J Global General Counsel Sep 01 '23 Sale 161.15 25 4,029 7,408 Sep 07 03:44 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Option Exercise 57.76 5,675 327,788 442,605 Aug 17 01:39 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Sale 183.20 5,675 1,039,647 436,930 Aug 17 01:39 PM Douglas Robert Andrew President and COO Aug 15 '23 Sale 181.01 1,500 271,515 250,526 Aug 16 01:51 PM Rider Michael J Global General Counsel Aug 01 '23 Sale 224.12 25 5,603 5,186 Aug 02 05:30 PM Farrell Michael J. Chief Executive Officer Jul 17 '23 Option Exercise 57.76 5,675 327,788 442,605 Jul 19 12:13 PM Farrell Michael J. Chief Executive Officer Jul 17 '23 Sale 221.27 5,675 1,255,686 436,930 Jul 19 12:13 PM Douglas Robert Andrew President and COO Jul 17 '23 Sale 222.22 1,500 333,330 252,026 Jul 18 05:02 PM Ghoshal Kaushik President, SaaS Business Jul 13 '23 Sale 220.00 500 110,000 11,787 Jul 14 12:26 PM Rider Michael J Global General Counsel Jul 03 '23 Sale 217.21 25 5,430 5,211 Jul 05 02:13 PM Farrell Michael J. Chief Executive Officer Jun 15 '23 Option Exercise 57.76 5,675 327,788 442,605 Jun 16 05:17 PM Farrell Michael J. Chief Executive Officer Jun 15 '23 Sale 217.39 5,675 1,233,716 436,930 Jun 16 05:17 PM Douglas Robert Andrew President and COO Jun 15 '23 Sale 216.27 1,500 324,405 253,526 Jun 20 12:02 PM PENDARVIS DAVID Chief Administrative Officer Jun 05 '23 Sale 219.79 1,500 329,685 89,729 Jun 07 12:20 PM Ghoshal Kaushik President, SaaS Business Jun 02 '23 Sale 220.00 500 110,000 12,287 Jun 06 01:18 PM
Index RUT
P/E -
EPS (ttm) -1.05
Insider Own 21.18%
Shs Outstand 57.82M
Perf Week 6.42%
Market Cap 840.23M
Forward P/E 145.08
EPS next Y 0.09
Insider Trans -2.23%
Shs Float 53.75M
Perf Month 16.39%
Income -60.00M
PEG -
EPS next Q -0.05
Inst Own 79.31%
Short Float 8.89%
Perf Quarter 0.83%
Sales 219.70M
P/S 3.82
EPS this Y 55.00%
Inst Trans 0.63%
Short Ratio 7.44
Perf Half Y 48.78%
Book/sh 0.30
P/B 45.31
EPS next Y 132.84%
ROA -31.06%
Short Interest 4.78M
Perf Year 35.69%
Cash/sh 1.55
P/C 8.67
EPS next 5Y 16.50%
ROE -472.61%
52W Range 7.07 - 15.43
Perf YTD 27.45%
Dividend Est. -
P/FCF -
EPS past 5Y 10.81%
ROI -41.69%
52W High -13.04%
Beta 1.33
Dividend TTM -
Quick Ratio 2.96
Sales past 5Y 44.65%
Gross Margin 66.85%
52W Low 89.82%
ATR (14) 0.50
Dividend Ex-Date -
Current Ratio 3.21
EPS Y/Y TTM 18.05%
Oper. Margin -15.05%
RSI (14) 58.71
Volatility 3.45% 3.95%
Employees 273
Debt/Eq 6.87
Sales Y/Y TTM 40.45%
Profit Margin -27.31%
Recom 1.12
Target Price 22.29
Option/Short Yes / Yes
LT Debt/Eq 6.81
EPS Q/Q 14.85%
Payout -
Rel Volume 0.58
Prev Close 13.59
Sales Surprise 3.61%
EPS Surprise 45.49%
Sales Q/Q 42.21%
Earnings May 07 AMC
Avg Volume 642.52K
Price 13.42
SMA20 6.39%
SMA50 2.88%
SMA200 22.65%
Trades
Volume 370,217
Change -1.25%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Upgrade
Barclays
Equal Weight → Overweight
$10 → $16
Jun-23-22 Initiated
Needham
Buy
$18
May-12-22 Upgrade
Barclays
Underweight → Equal Weight
$8 → $10
Jan-20-22 Upgrade
Truist
Hold → Buy
$11
May-06-21 Upgrade
Mizuho
Neutral → Buy
$15
Apr-08-21 Reiterated
H.C. Wainwright
Buy
$20 → $22
Feb-24-21 Downgrade
Truist
Buy → Hold
$12
Jul-07-20 Downgrade
Mizuho
Buy → Neutral
$8 → $3
Feb-06-20 Resumed
Mizuho
Buy
Nov-26-19 Initiated
SVB Leerink
Outperform
$25
Sep-05-19 Resumed
Mizuho
Buy
$30
Jun-28-19 Initiated
Wells Fargo
Market Perform
$16
Jun-11-19 Initiated
Barclays
Underweight
$13
Mar-20-19 Initiated
SunTrust
Buy
$30
Feb-14-19 Initiated
H.C. Wainwright
Buy
$37
Jan-29-19 Initiated
Stifel
Buy
$27
Show Previous Ratings
May-20-24 08:30AM
May-16-24 02:54AM
02:54AM
May-15-24 08:30AM
May-10-24 06:55PM
09:10AM
Loading…
09:10AM
May-08-24 11:09AM
07:24AM
(Thomson Reuters StreetEvents)
03:53AM
May-07-24 08:58PM
06:35PM
05:46PM
04:05PM
May-02-24 07:37AM
Apr-23-24 04:30PM
10:39AM
Loading…
Apr-21-24 10:39AM
Apr-17-24 04:05PM
Apr-12-24 04:05PM
Mar-26-24 08:00AM
Mar-14-24 07:04AM
Mar-13-24 09:55AM
Mar-11-24 07:00AM
Mar-08-24 04:05PM
03:24PM
12:30PM
(Thomson Reuters StreetEvents)
Mar-07-24 10:34PM
09:53PM
04:05PM
Mar-04-24 08:28PM
Mar-01-24 08:30AM
08:30AM
Loading…
Feb-27-24 08:30AM
Feb-22-24 04:30PM
Feb-09-24 04:05PM
Feb-02-24 09:10PM
Jan-16-24 05:28PM
Jan-12-24 04:23PM
Jan-09-24 06:21PM
Jan-04-24 04:05PM
Dec-20-23 08:00AM
Dec-08-23 04:30PM
Nov-13-23 09:08AM
Nov-10-23 05:16PM
Nov-07-23 04:16PM
Nov-06-23 08:45AM
Nov-01-23 08:45AM
Oct-25-23 08:45AM
08:45AM
Oct-08-23 06:41PM
Sep-29-23 04:05PM
Sep-13-23 04:10PM
Sep-09-23 01:03PM
Sep-03-23 05:29AM
Aug-29-23 08:45AM
Aug-27-23 07:20PM
Aug-23-23 06:53PM
Aug-21-23 08:45AM
Aug-08-23 09:15AM
08:45AM
Aug-02-23 05:45PM
04:05PM
Jul-27-23 11:42AM
08:45AM
Jul-26-23 10:02AM
08:45AM
Jul-19-23 08:45AM
Jul-15-23 07:30AM
Jun-29-23 09:00AM
Jun-22-23 08:45AM
Jun-08-23 04:05PM
Jun-02-23 06:38AM
May-16-23 01:44PM
May-09-23 05:25PM
04:01PM
04:01PM
May-05-23 01:37PM
Apr-17-23 11:05AM
Apr-04-23 10:39AM
Mar-11-23 06:38AM
Mar-09-23 10:12AM
(Thomson Reuters StreetEvents)
Mar-08-23 05:35PM
04:05PM
Feb-28-23 08:45AM
Feb-27-23 08:45AM
Feb-22-23 08:45AM
Feb-10-23 11:07AM
Jan-31-23 08:45AM
Jan-30-23 12:02PM
07:09AM
Jan-28-23 08:00AM
Jan-23-23 09:00AM
08:00AM
Jan-20-23 01:54PM
Jan-19-23 01:15PM
Jan-18-23 08:45AM
Jan-03-23 10:03AM
Dec-08-22 08:45AM
Dec-07-22 10:00AM
09:17AM
Nov-10-22 05:57AM
Nov-08-22 06:25PM
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GILL DAVID N Director May 14 '24 Sale 12.60 6,718 84,654 33,964 May 15 05:20 PM Malik Vikram Director May 13 '24 Sale 12.93 28,000 362,012 254,014 May 15 05:19 PM GILL DAVID N Director May 13 '24 Sale 12.72 3,643 46,356 40,682 May 15 05:20 PM MOATAZEDI DAVID See Remarks May 10 '24 Sale 12.72 16,051 204,127 673,563 May 14 08:56 PM Avelar Rui See Remarks May 10 '24 Sale 12.72 3,441 43,761 368,847 May 14 08:56 PM Beaver Sandra Chief Financial Officer May 10 '24 Sale 12.72 2,423 30,814 151,778 May 14 08:55 PM MOATAZEDI DAVID See Remarks Mar 27 '24 Sale 13.86 6,236 86,431 689,614 Mar 29 07:08 PM MOATAZEDI DAVID See Remarks Mar 19 '24 Sale 13.92 96,566 1,344,604 695,850 Mar 21 06:08 PM Avelar Rui See Remarks Mar 19 '24 Sale 13.92 27,603 384,350 372,288 Mar 21 06:09 PM Beaver Sandra Chief Financial Officer Mar 19 '24 Sale 13.92 5,672 78,978 154,201 Mar 21 06:09 PM MOATAZEDI DAVID See Remarks Feb 22 '24 Sale 13.08 7,706 100,804 792,416 Feb 23 08:27 PM Beaver Sandra Chief Financial Officer Feb 22 '24 Sale 13.08 1,821 23,821 159,873 Feb 23 08:27 PM Avelar Rui See Remarks Feb 22 '24 Sale 13.08 1,821 23,821 399,891 Feb 23 08:27 PM Parschauer Karah Herdman Director Jan 30 '24 Sale 13.14 11,931 156,733 31,243 Feb 02 04:57 PM MOATAZEDI DAVID See Remarks Dec 08 '23 Sale 9.73 31,300 304,505 603,944 Dec 08 06:15 PM MOATAZEDI DAVID See Remarks Dec 06 '23 Sale 10.09 51,348 517,891 635,244 Dec 08 06:15 PM Medytox Inc. Former 10% Owner Oct 16 '23 Sale 7.50 1,690,663 12,679,972 3,381,326 Oct 18 04:21 PM Beaver Sandra Chief Financial Officer Sep 06 '23 Sale 9.70 3,178 30,827 113,368 Sep 08 08:54 PM MOATAZEDI DAVID See Remarks Aug 16 '23 Sale 10.27 14,778 151,770 686,592 Aug 16 08:25 PM Beaver Sandra Chief Financial Officer Aug 16 '23 Sale 10.27 2,211 22,707 116,546 Aug 16 08:25 PM Avelar Rui See Remarks Aug 16 '23 Sale 10.27 2,211 22,707 353,386 Aug 16 08:25 PM Malik Vikram Director Aug 15 '23 Buy 7.41 174,967 1,296,505 275,550 Aug 15 04:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite